Novo Nordisk to pay $2 billion for new weight loss drug
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...
FoodNavigator2d
Outcry as Novo Nordisk Foundation looks at UPF classification
It stressed that while the funding came from the Novo Nordisk Foundation, the project itself would be carried out by ...
Novo Nordisk, The United Laboratories announce license agreement for UBT251
The United Laboratories International Holdings Limited and Novo Nordisk (NVO) announced earlier that Novo Nordisk and TUL’s wholly-owned ...
Germany’s SAP Overtakes Wegovy Maker Novo Nordisk as Europe’s Most Valuable Company
The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo ...
Novo Nordisk Stock (NVO) Plunges as It Shells Out $2 Billion on Chinese Weight Drug
Novo Nordisk (NVO) just agreed to shell out up to $2 billion for the global rights to a Chinese weight-loss drug—and the market wasn’t ...